Unknown

Dataset Information

0

Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.


ABSTRACT: Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma in adults. DLBCL exhibits highly aggressive and systemic progression into multiple tissues in patients, particularly in lymph nodes. Whole-body 18F-fluodeoxyglucose positron emission tomography ([18F]FDG-PET) imaging has an essential role in diagnosing DLBCL in the clinic; however, [18F]FDG-PET often faces difficulty in differentiating malignant tissues from certain nonmalignant tissues with high glucose uptake. We have developed a PET imaging strategy for DLBCL that targets poly[ADP ribose] polymerase 1 (PARP1), the expression of which has been found to be much higher in DLBCL than in healthy tissues. In a syngeneic DLBCL mouse model, this PARP1-targeted PET imaging approach allowed us to discriminate between malignant and inflamed lymph nodes, whereas [18F]FDG-PET failed to do so. Our PARP1-targeted PET imaging approach may be an attractive addition to the current PET imaging strategy to differentiate inflammation from malignancy in DLBCL.

SUBMITTER: Tang J 

PROVIDER: S-EPMC5594659 | BioStudies | 2017-01-01

SECONDARY ACCESSION(S): NCT00576654

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC5807531 | BioStudies
2015-01-01 | S-EPMC4289066 | BioStudies
2019-01-01 | S-EPMC6333408 | BioStudies
2020-01-01 | S-EPMC7082024 | BioStudies
2018-01-01 | S-EPMC6475957 | BioStudies
2020-01-01 | S-EPMC7069975 | BioStudies
2019-01-01 | S-EPMC6647180 | BioStudies
2016-01-01 | S-EPMC5056699 | BioStudies
2020-01-01 | S-EPMC7051076 | BioStudies
1000-01-01 | S-EPMC6134939 | BioStudies